Research

Discover Me

Discover Me is a nationwide research study looking at how health and genetic information can allow us to better understand disease.

By joining Discover Me United Kingdom you can get insights into your health and genetic ancestry.
You can get more information at Discover Me (discovermestudy.com)

Patients of Abbeywell Surgery can take part if you are aged 18 or over and are able to consent for yourself

UPDATE: Due to the success of the study and large number of recruited participants, there may be a delay to you receiving your sample collection kit. The central team are working to get these to you asap.

If you would like to more information or timelines please contact their participant team directly on [email protected] or call 02038668941

Please visit https://www.discovermestudy.com/dmuk for more information.

DaRe2THINK Trial

This trial is looking to see whether the use of blood thinning tablets reduce the chances of stroke or dementia in later life

The Trial is for patients with Atrial Fibrillation who are under 75 years old

You may be required to take blood thinning tablets that are already widely used and would be part of your future care anyway

Follow up will be automatic with no extra visits for patients, all you need to do is complete some questionnaires every 6 months using your phone, tablet or computer at home.

Please visit https://www.dare2think.org/ for more information.

Asymptomatic Trial

The aim of the ASYMPTOMATIC trial is to find out the best way for children and young people with asthma to use their inhaled corticosteroids (preventer inhaler).

At the moment, children and young people in the UK are advised to take their corticosteroid inhaler every day. Although this approach appears to help prevent asthma attacks, it may not be needed in all children with mild asthma.

They could perhaps instead use a corticosteroid inhaler only on days when they have asthma symptoms, such as cough, wheeze, or shortness of breath.

This study will measure if the number of asthma attacks is different between children who take their corticosteroid inhaler everyday (the “daily” group) and those who take it only when they have symptoms (the “symptom-driven group”).

Please visit https://asymptomatic-trial.org.uk/ for more information.

Optimise 2

Many older adults take multiple medications to manage high blood pressure, which can sometimes increase the risk of side-effects such as dizziness and falls. Earlier research suggests that carefully reducing the number of blood pressure tablets can be safe in the short term, but we don’t yet know the longer-term effects.

This study will look at whether reducing blood pressure medications in people aged 75 and over, who currently have normal blood pressure, is safe and beneficial. We aim to understand whether deprescribing affects hospital admissions or death, improves quality of life, and could save money for the NHS.

Please visit https://www.phctrials.ox.ac.uk/recruiting-trials/optimise-2 for more information.

PARC

Children and young people who need to use a blue reliever inhaler more than 2-3 times per week are more likely to have severe asthma/wheeze attacks. It has been recommended that children and young people prescribed high numbers of blue reliever inhalers in the past 12 months should have a check up.

We are aiming to find out whether an enhanced nurse-led check up will reduce the number of asthma/wheeze attacks experienced by young people using too many blue reliever inhalers

Children prescribed 6 or more blue reliever inhalers in a year have been invited to the study.

Please visit https://generic.wordpress.soton.ac.uk/parc/ for more information.

Cow's Milk Protein Allergy (CMPA) Studies

We are currently running two studies for infants with cow’s milk protein allergy.

If your child may be eligible, we will contact you directly.

However, if you’d like to find out more or think your baby might benefit from taking part, please feel free to get in touch with our research team.

Research Mobile: 07547224832

Research Email: [email protected]

AFLOAT

https://youtu.be/6vcXBmA0nxU?si=NCusSadCQ4_QkNCv

AFLOAT is a national research study for older adults with uncomplicated chest infections. It compares recovery between those who take antibiotics and those who take a dummy capsule, helping us understand when antibiotics are truly needed.

If you may be eligible, we will discuss the study with you when you contact us about your symptoms, and you will continue to receive your usual NHS care throughout.

Please visit https://www.youtube.com/watch?v=6vcXBmA0nxU for more information.

Trecony

The TRECONY study is evaluating an investigational asthma inhaler that uses a new climate friendly alternative propellant designed to have a lower global warming potential.

We’re looking for adults with mild to moderate asthma who currently use a daily inhaled steroid at low or medium dose for asthma treatment (such as beclometasone, budesonide, ciclesonide, fluticasone, or mometasone) associated or not with a bronchodilator

The study lasts about 20 weeks and requires 8 visits to the site. Study drugs, study visits, and study-related tests and examinations are provided at no cost.